Literature DB >> 17488692

Molecular genetic analyses in familial and sporadic congenital primary erythrocytosis.

Susana Rives1, Heike L Pahl, Lourdes Florensa, Beatriz Bellosillo, Andrea Neusuess, Jesus Estella, Klaus-Michael Debatin, Elisabeth Kohne, Klaus Schwarz, Holger Cario.   

Abstract

Dominant mutations in the erythropoietin receptor (EPOR) gene account for only about 15% of cases of primary congenital erythrocytosis. To search for molecular alterations in patients with this disorder. Sixteen patients with Epo <10 mU/mL were studied, 3 were related. Analyses included EPOR and JAK2 gene sequencing, quantitative PRV-1 RT-PCR, and erythroid colony assays. A novel sporadic EPOR 1453G->A (Trp439Stop) mutation was detected. All familial cases, varied in phenotype, presented the EPOR 1414C->G (Tyr426Stop) mutation. JAK2 mutations are not involved in the pathogenesis of primary congenital erythrocytosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488692     DOI: 10.3324/haematol.10787

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  12 in total

1.  Clinical utility gene card for: familial erythrocytosis.

Authors:  Kais Hussein; Melanie Percy; Mary Frances McMullin
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

2.  A case of primary familial congenital polycythemia with a novel EPOR mutation: possible spontaneous remission/alleviation by menstrual bleeding.

Authors:  Naohisa Toriumi; Makoto Kaneda; Naoki Hatakeyama; Hiromi Manabe; Kazuki Okajima; Yukari Sakurai; Masayo Yamamoto; Takeo Sarashina; Katsuya Ikuta; Hiroshi Azuma
Journal:  Int J Hematol       Date:  2018-04-05       Impact factor: 2.490

3.  A novel mutation of the erythropoietin receptor gene associated with primary familial and congenital polycythaemia.

Authors:  Kacey O'Rourke; David J Fairbairn; Kathryn A Jackson; Kirk L Morris; Siok-Keen Tey; Glen A Kennedy
Journal:  Int J Hematol       Date:  2011-03-25       Impact factor: 2.490

4.  Clinical Characteristics of Pediatric Patients with Congenital Erythrocytosis: A Single-Center Study.

Authors:  Sema Aylan Gelen; Nazan Sarper; Emine Zengin; İnci Tahsin; Mehmet Azizoğlu
Journal:  Indian J Hematol Blood Transfus       Date:  2021-08-25       Impact factor: 0.900

5.  EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.

Authors:  Silverio Perrotta; Valeria Cucciolla; Marcella Ferraro; Luisa Ronzoni; Annunziata Tramontano; Francesca Rossi; Anna Chiara Scudieri; Adriana Borriello; Domenico Roberti; Bruno Nobili; Maria Domenica Cappellini; Adriana Oliva; Giovanni Amendola; Anna Rita Migliaccio; Patrizia Mancuso; Ines Martin-Padura; Francesco Bertolini; Donghoon Yoon; Josef T Prchal; Fulvio Della Ragione
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

Review 6.  Advances in understanding the pathogenesis of primary familial and congenital polycythaemia.

Authors:  Lily J Huang; Yu-Min Shen; Gamze B Bulut
Journal:  Br J Haematol       Date:  2010-01-20       Impact factor: 6.998

7.  Congenital and acquired polycythemias.

Authors:  Fabian P Siegel; Petro E Petrides
Journal:  Dtsch Arztebl Int       Date:  2008-01-25       Impact factor: 5.594

Review 8.  Back to biology: new insights on inheritance in myeloproliferative disorders.

Authors:  Evan M Braunstein; Alison R Moliterno
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

Review 9.  Progress in detecting cell-surface protein receptors: the erythropoietin receptor example.

Authors:  Steve Elliott; Angus Sinclair; Helen Collins; Linda Rice; Wolfgang Jelkmann
Journal:  Ann Hematol       Date:  2013-12-14       Impact factor: 3.673

10.  The effect of erythropoietin on normal and neoplastic cells.

Authors:  Steve Elliott; Angus M Sinclair
Journal:  Biologics       Date:  2012-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.